Study on Antibodies in Pregnant Women with Malaria
Author Information
Author(s): Juliette Guitard, Gilles Cottrell, Nellie Moulopo, Ali Salanti, Tengfei Li, Sokhna Sow, Philippe Deloron, Nicaise Tuikue Ndam
Primary Institution: Institut de Recherche pour le Développement (IRD), Université Paris Descartes, France
Hypothesis
How do anti-VAR2CSA IgG3 levels differ between primigravidae and multigravidae pregnant women infected by Plasmodium falciparum?
Conclusion
Higher levels of IgG3 in uninfected primigravidae suggest a protective role of these antibodies against placental malaria.
Supporting Evidence
- Primigravidae with uninfected placentas had higher IgG3 levels than those with infected placentas.
- Multigravidae showed higher IgG3 levels associated with infected placentas.
- The study followed 306 pregnant women from enrolment to delivery.
Takeaway
This study found that first-time pregnant women have higher protective antibodies against malaria than those who have been pregnant before.
Methodology
ELISA was used to compare VAR2CSA-specific IgG subclasses in pregnant women at enrolment and delivery.
Potential Biases
Potential confounding factors such as febrile episodes were considered but may still influence results.
Limitations
The study had a small sample size for some analyses, which may limit the power of the results.
Participant Demographics
The study included 306 pregnant women from Senegal, with 22.3% being primigravidae and 77.7% multigravidae.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website